Compare Natera Inc. Common Stock (NTRA) vs iShares TIPS Bond ETF (TIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs iShares TIPS Bond ETF — how do they compare? Natera Inc. Common Stock trades at $394 (market cap $57.03B), while iShares TIPS Bond ETF trades at $105.3 (market cap $14.33B). The key difference: Natera Inc. Common Stock is far larger — about 4× iShares TIPS Bond ETF's market cap, and Natera Inc. Common Stock is trading nearer its 52-week high, iShares TIPS Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and iShares TIPS Bond ETF for 64 Days on average.
| NTRA | TIP | |
|---|---|---|
Market Cap | $57.03B | $14.33B |
Volume | 1,131,157 | 1,485,284 |
Sector | Health | Fixed Income |
52-Week High | $425.64 | $112.20 |
52-Week Low | $179.42 | $103.98 |
Typical Hold Time | 0 Days | 64 Days |
Enterprise Value | $56.18B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
TIP trades at $104.56 with minimal daily movement (+0.06%). Technical indicators show a bearish bias with moving averages signaling caution, though oscillators remain neutral. The ETF shows limited price volatility with support at $104 and resistance at $105. Recent institutional activity includes Envestnet Asset Management increasing its stake by 3.5% in the latest quarter.
The ETF faces headwinds from rising Treasury yields and bond market volatility, though its inflation-protected structure provides defensive characteristics. Key risks include continued bond market selloffs and geopolitical tensions affecting oil prices. The upcoming dividend payment of $0.78 scheduled for August 2026 offers income stability amid market uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About iShares TIPS Bond ETF
TIP is the flagship ETF for U.S. Treasury Inflation-Protected Securities (TIPS). It tracks an index of government bonds whose principal value adjusts based on the Consumer Price Index (CPI), providing a direct hedge against rising inflation.
Read more on TIP →
